MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Ultragenyx Pharmaceutical Company Profile (NASDAQ:RARE)

Consensus Ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) (?)
Ratings Breakdown: 1 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.91)
Consensus Price Target: $107.00 (3.67% downside)

Analysts' Ratings History for Ultragenyx Pharmaceutical (NASDAQ:RARE)
Show:
DateFirmActionRatingPrice TargetActions
8/31/2015Raymond JamesInitiated CoverageOutperform$125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015Morgan StanleyLower Price Target$126.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2015JPMorgan Chase & Co.Reiterated RatingOverweight$119.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015Morgan StanleyDowngradeOverweight -> Equal Weight$77.00 -> $126.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/13/2015SunTrustBoost Price TargetBuy$82.00 -> $119.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015Cowen and CompanyReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2015WedbushReiterated RatingOutperform$122.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2015JMP SecuritiesInitiated CoverageOutperform$119.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Canaccord GenuityBoost Price TargetBuy$78.00 -> $97.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/3/2015JPMorgan Chase & Co.Reiterated RatingOverweight$73.00 -> $100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2015Cowen and CompanyReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015JPMorgan Chase & Co.Reiterated RatingOverweight$66.00 -> $73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Jefferies GroupReiterated RatingBuy$74.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2015Canaccord GenuityReiterated RatingBuy$68.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015JPMorgan Chase & Co.Reiterated RatingOverweight$66.00 -> $73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Jefferies GroupReiterated RatingBuy$74.00 -> $80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2015Canaccord GenuityBoost Price TargetBuy$68.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015WedbushInitiated CoverageOutperform$74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015MLV & Co.Initiated CoverageBuy$79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015Canaccord GenuityReiterated RatingBuy$68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/26/2015JPMorgan Chase & Co.Reiterated RatingOverweight$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015CRT CapitalInitiated CoverageBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015Canaccord GenuityBoost Price TargetBuy$62.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015Canaccord GenuitySet Price TargetBuy$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Canaccord GenuityInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2014SunTrustInitiated CoverageBuy$82.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2014Jefferies GroupInitiated CoverageBuy$74.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014Robert W. BairdInitiated CoverageOutperform$64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Morgan StanleyInitiated CoverageOverweight$81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014Canaccord GenuityInitiated CoverageBuy$85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2014JPMorgan Chase & Co.Initiated CoverageOverweight$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha